Medicinal Research Reviews

Papers
(The H4-Index of Medicinal Research Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Front Cover Image, Volume 41, Issue 4358
Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis136
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands121
101
Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels91
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach91
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands81
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease76
76
74
Issue Information67
Issue Information65
β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo57
55
Front Cover Image, Volume 43, Issue 453
52
Front Cover Image, Volume 44, Issue 452
Issue Information51
The following articles for this Special Issue were published before this collection was released. They can be found in their respective issues or online.47
Front Cover Image, Volume 41, Issue 646
Issue Information44
44
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies43
Galectin‐8 inhibition and functions in immune response and tumor biology42
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness40
Emerging potentials of Fe‐based nanomaterials for chiral sensing and imaging39
The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases38
The application of zebrafish patient‐derived xenograft tumor models in the development of antitumor agents38
Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery37
Natural products as Zika antivirals36
Key characters of glycodrugs32
Microglia‐derived galectin‐3 in neuroinflammation; a bittersweet ligand?31
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery31
0.043751955032349